Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma

Cancer Letters

Volumn 133, Issue 1, 1998, Pages 19-26

  Sugiyama, Tomomi ^a   Sadzuka, Yasuyuki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Adriamycin; Biochemical modulation; Green tea; M5076 ovarian sarcoma; Theanine

Indexed keywords

DOXORUBICIN; PLANT EXTRACT; THEOPHYLLINE ETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TISSUE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LIVER; LUNG; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; TEA;

ANIMALS; DOXORUBICIN; DRUG SYNERGISM; FEMALE; GLUTAMATES; MALE; MICE; OVARIAN NEOPLASMS; SARCOMA, EXPERIMENTAL; TEA; TUMOR CELLS, CULTURED;

EID: 0032433184     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00185-2     Document Type: Article

References (25)

1. Budd G.T., Fleming R.M., Bukowski R.M., McCracken J.D., Rivkin S.E., O R.M. rsquo;Bryan, S.P. Balcerzak, J.S. Macdonald, 5-Fluorouracil and folinic acid in the treatment of advanced colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. J. Clin. Oncol. 5:1989;272-277.
2. Onoda J.M., Nelson K.K., Taylor J.D., Honn K.V. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum (II). Cancer Res. 49:1989;2844-2850.
3. Konishi T., Mochizuki Y. Biochemical modulation. CRC. 1:1992;88-97.
4. Sadzuka Y., Mochizuki E., Takino Y. Mechanism of caffeine modulation of antitumor activity of adriamycin. Toxicol. Lett. 75:1995;39-49.
5. Sadzuka Y., Iwazaki A., Miyagishima A., Nozawa Y., Hirota S. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity. Jpn. J. Cancer Res. 86:1995;594-599.
6. Sadzuka Y., Sugiyama T., Miyagishima A., Nozawa Y., Hirota S. The effects of theanine, a novel biochemical modulator, on the antitumor activity of adriamycin. Cancer Lett. 105:1996;203-209.
7. Sakato Y. Studies on the chemical constituents of tea. Nippon Nogeikagaku Kaishi. 23:1949;262-267.
8. Graham H.N. Green tea composition, consumption and polyphenol chemistry. Prev. Med. 21:1992;334-350.
9. Talmadge J.E., Hart I.R. Morphologic studies on a murine reticulum cell sarcoma (histiocytic sarcoma) of histiocytic origin and its metastasis. Vet. Pathol. 20:1983;342-352.
10. Mayhew E., Rustum Y., Vail W.J. Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin. Cancer Drug Delivery. 1:1983;43-58.
11. Yamaoka M., Yamamoto T., Masaki T., Ikeyama S., Sudo K., Fujita T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Res. 53:1993;4262-4267.
12. Shinomiya N., Shinomiya M., Wakiyama H., Katsura Y., Rokutanda M. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptic cell death. Exp. Cell Res. 210:1994;236-242.
13. Zou Y., Ling Y.H., Van N.T., Priebe W., Perez-Soler R. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline with non-cross resistance properties. Cancer Res. 54:1994;1479-1484.
14. Carter K.S. The clinical evaluation of analogs-III. Anthracyclines. Cancer Chemother. Pharmacol. 4:1980;5-10.
15. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 197:1977;165-167.
16. Sazuka Y., Yoshikawa K., Tanizawa H., Takino Y. Effect of doxorubicin on lipid peroxide levels in tissues of mice. Jpn. J. Cancer Res. 78:1987;1281-1286.
17. Hamada H., Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 83:1986;7785-7789.
18. Simon S.M., Schindlert M. Cell biological mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sci. USA. 91:1994;3497-3504.
19. Lorico A., Rappa G., Srimatkandada S., Catapano C.V., Fernandes D.J., Germino J.F., Sartorelli A.C. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistant-associated protein (MRP) gene. Cancer Res. 55:1995;4352-4360.
20. Ishikawa T., Wright C.D., Ishizuka H. GS-X pump is functionally overexpressed in cis-diamminedichloro-platinum(II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem. 269:1994;29085-29093.
21. Kang Y., Perry R.R. Effect of (-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance. Cancer Res. 54:1994;2952-2958.
22. Pouliot J.F., L F. rsquo;Heureux, Z. Liu, R.K. Prichard, E. Georges, Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 53:1997;17-25.
23. Nagasawa K., Ohnishi N., Yokoyama T. Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells and comparison with those of its analogs. Jpn. J. Cancer Res. 88:1997;750-759.
24. Wang Z.Y., Huang M.T., Ferraro T., Wong C.Q., Lou Y.R., Reuhl K., Iatropoulos M., Yang C.S., Conney A.H. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-o-tetradecanoylphorbol-13-acetate in the skin of SHK-1 mice. Cancer Res. 52:1992;1162-1170.
25. Qin G., Gopalan-Kriczky P., Su J., Ning Y., Lotliker P.D. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Cancer Lett. 112:1997;149-154.